| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | WARS |
| Uniprot No | P23381 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 2-471aa |
| 氨基酸序列 | PNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQ |
| 预测分子量 | 60.0 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于WARS(色氨酸-tRNA合成酶)重组蛋白的参考文献示例(注：部分内容基于领域内代表性研究概括，建议核实原文)：
1. **"Tryptophanyl-tRNA synthetase as a human autoantigen"**
*作者：B. A. Mock et al.*
**摘要**：探讨WARS作为自身抗原在自身免疫疾病中的作用，研究重组人WARS蛋白的免疫原性及其与抗体的相互作用机制。
2. **"Non-canonical roles of tryptophanyl-tRNA synthetase in immune regulation"**
*作者：K. Wakasugi & P. Schimmel*
**摘要**：揭示重组WARS蛋白在炎症反应中的非经典功能，包括调控细胞因子分泌和巨噬细胞活化，提示其作为治疗靶点的潜力。
3. **"Recombinant human WARS expression in E. coli: Purification and enzymatic characterization"**
*作者：J. Lee et al.*
**摘要**：描述通过大肠杆菌系统高效表达重组WARS蛋白的优化方法，分析其酶活性及结构稳定性，为工业规模化生产提供参考。
4. **"WARS promotes tumor progression through angiogenesis in breast cancer"**
*作者：M. Zhou et al.*
**摘要**：利用重组WARS蛋白验证其在乳腺癌微环境中诱导血管生成的作用机制，强调其作为癌症生物标志物的可能性。
*提示：上述文献标题与内容为领域内典型研究方向概括，实际引用时建议通过PubMed或Google Scholar核对具体作者及发表年份。*
**Background of WARS Recombinant Protein**
WARS, or tryptophanyl-tRNA synthetase, is a member of the aminoacyl-tRNA synthetase (aaRS) family, enzymes essential for protein synthesis. It catalyzes the attachment of tryptophan to its cognate tRNA during translation, ensuring the accurate incorporation of amino acids into growing polypeptide chains. Beyond its canonical role, WARS has garnered attention for its non-canonical functions, including immune modulation, angiogenesis regulation, and involvement in stress responses.
The recombinant form of WARS is produced via genetic engineering, typically using expression systems like *E. coli*, yeast, or mammalian cells. Recombinant technology enables large-scale production of highly pure, functional WARS protein, bypassing limitations of native purification from biological tissues. This approach allows precise control over post-translational modifications and structural variants, facilitating research and therapeutic applications.
Interest in WARS recombinant protein stems from its dual roles in health and disease. In pathological contexts, dysregulated WARS expression is linked to cancers, neurodegenerative disorders, and autoimmune diseases. For example, WARS acts as a pro-inflammatory cytokine in certain cancers, promoting tumor angiogenesis, while in neurological conditions, its aberrant activity may contribute to protein misfolding. Recombinant WARS is thus a valuable tool for studying disease mechanisms and screening potential therapeutics.
Additionally, WARS recombinant protein has potential diagnostic and therapeutic applications. It is explored as a biomarker for specific cancers and as a target for small-molecule inhibitors. Its immunomodulatory properties also make it a candidate for developing anti-inflammatory or anti-angiogenic drugs.
Overall, WARS recombinant protein bridges fundamental biology and translational research, offering insights into protein synthesis regulation and paving the way for novel medical interventions.
×
